Duke Researchers Testing Novel Therapeutics for Early and Acute Stages of COVID-19
During the acute stage of COVID-19, the immune system mounts an overwhelming inflammatory response to the SARS-CoV-2 virus. This influx of proinflammatory proteins, known as the “cytokine storm,” causes damage to lung tissue and results in acute respiratory distress syndrome (ARDS).
Great COVID-19 Saves: Rapid Testing in the Intensive Care Unit
The emergence of the highly infectious SARS-CoV-2 virus posed a new challenge to caring for trauma patients in the intensive care unit (ICU). At the onset of the COVID-19 pandemic, trauma surgeons faced a serious dilemma: how do you protect these highly vulnerable patients from the virus while also protecting your colleagues on the front lines?
Developing a SARS-CoV-2 Vaccine: Adapting HIV Antibodies Research to Fight Against COVID-19
Photo above: SARS-CoV-2 vaccine currently in the testing phase
Great COVID-19 Saves: How ECMO Helped a Pregnant Patient Meet Her Newborn Son
Photo above: Takia Morrison is discharged after recovering from COVID-19
Black Voices in Healthcare: Bradley Collins, MD, Senior Faculty Member
This piece is part of a series featuring Black voices from the surgical and emergency medicine communities at Duke. Dr. Collins attended Duke University for medical school and completed his residency and research fellowship at Duke.
Black Voices in Healthcare: Hadiza S. Kazaure, MD, New Faculty Member
This piece is part of a series featuring Black voices from the surgical and emergency medicine communities at Duke.
Duke Tests Novel COVID-19 Therapy, Is Lead Enroller in International Trial
The early stage of COVID-19 offers a critical window of opportunity to prevent the progression of the disease to the acute state, when patients require supportive care.